1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. Xenios AG Acquires XOR Labs

M&A Deal Summary

Xenios AG Acquires XOR Labs

On February 22, 2016, Xenios AG acquired medical products company XOR Labs

Acquisition Highlights
  • This is Xenios AG’s 1st transaction in the Medical Products sector.
  • This is Xenios AG’s 1st transaction in Canada.
  • This is Xenios AG’s 1st transaction in Ontario.

M&A Deal Summary
Date 2016-02-22
Target XOR Labs
Sector Medical Products
Buyer(s) Xenios AG
Deal Type Add-on Acquisition

Target

XOR Labs

Toronto, Ontario, Canada
XOR Labs, Inc. is a medical device company in the fields of organ transplantation and diseased organ treatment.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Xenios AG

Heilbronn, Germany
Category Company
Sector Medical Products
DESCRIPTION

Xenios AG is a medical technology company involved in providing treatment of lung and cardiac failure.

DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal